Skip to main content
. 2020 Jul 29;12(8):709. doi: 10.3390/pharmaceutics12080709

Figure 3.

Figure 3

(A) X-ray powder diffraction (XRD) profile of the biogenic AgNPs. (B) Energy Dispersive X-Ray Analysis (EDX) spectrum of the biosynthesized AgNPs with their corresponding strong Ag signal at 3 keV.